The structure of human CD23 and its interactions with IgE and CD21

Journal of Experimental Medicine

Volumn 202, Issue 6, 2005, Pages 751-760

  Hibbert, Richard G ^a   Teriete, Peter ^a   Grundy, Gabrielle J ^b,e   Beavil, Rebecca L ^b   Reljić, Rajko ^b   Holers, V Michael ^c,d   Hannan, Jonathan P ^c   Sutton, Brian J ^b   Gould, Hannah J ^b   McDonnell, James M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF COLORADO   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD23 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN E; LECTIN;

ALLERGIC DISEASE; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; BINDING SITE; CONCENTRATION (PARAMETERS); IMMUNOGLOBULIN PRODUCTION; LIGAND BINDING; MOLECULAR INTERACTION; MOLECULAR WEIGHT; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; THREE DIMENSIONAL IMAGING;

BINDING SITES; CALCIUM; DOWN-REGULATION; HUMANS; IMMUNOGLOBULIN E; LECTINS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, COMPLEMENT 3D; RECEPTORS, IGE; SURFACE PLASMON RESONANCE; UP-REGULATION;

EID: 25144457128     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20050811     Document Type: Article

References (48)

1. Gould, H.J., R.L. Beavil, R. Reljic, J. Shi, C.W. Ma, B.J. Sutton, and R. Ghirlando. 1997. IgE homeostasis: is CD23 the safety switch? In IgE Regulation: Molecular Mechanisms. D. Vercelli, editor. John Wiley & Sons Inc., New York. 35-59.
2. Aubry, J.P., S. Pochon, P. Graber, K.U. Jansen, and J.Y. Bonnefoy. 1992. CD21 is a ligand for CD23 and regulates IgE production. Nature. 358:505-507.
3. Soilleux, E.J., R. Barten, and J. Trowsdale. 2000. DC-SIGN; a related gene, DC-SIGNR; and CD23 form a cluster on 19p13. J. Immunol. 165:2937-2942.
4. Mossalayi, M.D., M. Arock, G. Delespesse, H. Hofstetter, B. Bettler, A.H. Dalloul, E. Kilchherr, F. Quaaz, P. Debre, and M. Sarfati. 1992. Cytokine effects of CD23 are mediated by an epitope distinct from the IgE binding site. EMBO J. 11:4323-4328.
5. Shi, J., R. Ghirlando, R.L. Beavil, A.J. Beavil, M.B. Keown, R.J. Young, R.J. Owens, B.J. Sutton, and H.J. Gould. 1997. Interaction of the low-affinity receptor CD23/Fc epsilonRII lectin domain with the Fc epsilon3-4 fragment of human immunoglobulin E. Biochemistry. 36:2112-2122.
6. Aubry, J.P., S. Pochon, J.F. Gauchat, A. Nueda-Marin, V.M. Holers, P. Graber, C. Siegfried, and J.Y. Bonnefoy. 1994. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. J. Immunol. 152:5806-5813.
7. Wan, T., R.L. Beavil, S.M. Fabiane, A.J. Beavil, M.K. Sohi, M. Keown, R.J. Young, A.J. Henry, R.J. Owens, H.J. Gould, and B.J. Sutton. 2002. The crystal structure of IgE Fc reveals an asymmetrically bent conformation. Nat. Immunol. 3:681-686.
8. Wurzburg, B.A., S.C. Garman, and T.S. Jardetzky. 2000. Structure of the human IgE-Fc C epsilon 3-C epsilon 4 reveals conformational flexibility in the antibody effector domains. Immunity. 13:375-385.
9. Szakonyi, G., J.M. Guthridge, D. Li, K. Young, V.M. Holers, and X.S. Chen. 2001. Structure of complement receptor 2 in complex with its C3d ligand. Science. 292:1725-1728.
10. Padlan, E.A., and B.A. Helm. 1993. Modeling of the lectin-homology domains of the human and murine low-affinity Fc epsilon receptor (Fc epsilon RII/CD23). Receptor. 3:325-341.
11. Beavil, R.L., P. Graber, N. Aubonney, J.Y. Bonnefoy, and H.J. Gould. 1995. CD23/Fc epsilon RII and its soluble fragments can form oligomers on the cell surface and in solution. Immunology. 84:202-206.
12. Letellier, M., M. Sarfati, and G. Delespesse. 1989. Mechanisms of formation of IgE-binding factors (soluble CD23)-I. Fc epsilon R II bearing B cells generate IgE-binding factors of different molecular weights. Mol. Immunol. 26:1105-1112.
13. Schulz, O., B.J. Sutton, R.L. Beavil, J. Shi, H.F. Sewell, H.J. Gould, P. Laing, and F. Shakib. 1997. Cleavage of the low-affinity receptor for human IgE (CD23) by a mite cysteine protease: nature of the cleaved fragment in relation to the structure and function of CD23. Eur. J. Immunol. 27:584-588.
14. Gould, H.J., B.J. Sutton, A.J. Beavil, R.L. Beavil, N. McCloskey, H.A. Coker, D. Fear, and L. Smurthwaite. 2003. The biology of IgE and the basis of allergic disease. Annu. Rev. Immunol. 21:579-628.
15. Plater-Zyberk, C., and J.Y. Bonnefoy. 1995. Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nat. Med. 1:781-785.
16. Rosenwasser, L.J., W.W. Busse, R.G. Lizambri, T.A. Olejnik, and M.C. Totoritis. 2003. Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial. J. Allergy Clin. Immunol. 112:563-570.
17. Mavromatis, B.H., and B.D. Cheson. 2004. Novel therapies for chronic lymphocytic leukemia. Blood Rev. 18:137-148.
18. Richards, M.L., and D.H. Katz. 1990. The binding of IgE to murine Fc epsilon RII is calcium-dependent but not inhibited by carbohydrate. J. Immunol. 144:2638-2646.
19. Pochon, S., P. Graber, M. Yeager, K. Jansen, A.R. Bernard, J.P. Aubry, and J.Y. Bonnefoy. 1992. Demonstration of a second ligand for the low affinity receptor for immunoglobulin E (CD23) using recombinant CD23 reconstituted into fluorescent liposomes. J. Exp. Med. 176:389-397.
20. Pervushin, K., R. Riek, G. Wider, and K. Wuthrich. 1997. Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solution. Proc. Natl. Acad. Sci. USA. 94:12366-12371.
21. Cornilescu, G., F. Delaglio, and A. Bax. 1999. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J. Biomol. NMR. 13:289-302.
22. Zelensky, A.N., and J.E. Gready. 2003. Comparative analysis of structural properties of the C-type-lectin-like domain (CTLD). Proteins. 52:466-477.
23. Taylor, M.E., and K. Drickamer. 2003. Structure-function analysis of C-type animal lectins. Methods Enzymol. 363:3-16.
24. East, L., S. Rushton, M.E. Taylor, and C.M. Isacke. 2002. Characterization of sugar binding by the mannose receptor family member, Endo180. J. Biol. Chem. 277:50469-50475.
25. Nissim, A., S. Schwarzbaum, R. Siraganian, and Z. Eshhar. 1993. Fine specificity of the IgE interaction with the low and high affinity Fc receptor. J. Immunol. 150:1365-1374.
26. Altieri, A., D. Hinton, and R. Byrd. 1995. Association of biomolecular systems via pulsed field gradient NMR self-diffusion measurements. J. Am. Chem. Soc. 117:7566-7567.
27. Yin, J., A.E. Beuscher IV, S.E. Andryski, R.C. Stevens, and P.G. Schultz. 2003. Structural plasticity and the evolution of antibody affinity and specificity. J. Mol. Biol. 330:651-656.
28. Vercelli, D., B. Helm, P. Marsh, E. Padlan, R.S. Geha, and H. Gould. 1989. The B-cell binding site on human immunoglobulin E. Nature. 338:649-651.
29. Dierks, S.E., W.C. Bartlett, R.L. Edmeades, H.J. Gould, M. Rao, and D.H. Conrad. 1993. The oligomeric nature of the murine Fc epsilon RII/CD23. Implications for function. J. Immunol. 150:2372-2382.
30. Dyson, H.J., and P.E. Wright. 2002. Coupling of folding and binding for unstructured proteins. Curr. Opin. Struct. Biol. 12:54-60.
31. Carter, R.H., and D.T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 256:105-107.
32. Dempsey, P.W., and D.T. Fearon. 1996. Complement: instructing the acquired immune system through the CD21/CD19 complex. Res. Immunol. 147:71-75 (discussion 119-120).
33. Reljic, R., G. Cosentino, and H.J. Gould. 1997. Function of CD23 in the response of human B cells to antigen. Eur. J. Immunol. 27:572-575.
34. Payet, M., and D.H. Conrad. 1999. IgE regulation in CD23 knockout and transgenic mice. Allergy. 54:1125-1129.
35. Luo, H.Y., H. Hofstetter, J. Banchereau, and G. Delespesse. 1991. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. J. Immunol. 146:2122-2129.
36. Sherr, E., E. Macy, H. Kimata, M. Gilly, and A. Saxon. 1989. Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis. J. Immunol. 142:481-489.
37. Campbell, K.A., E.J. Studer, M.A. Kilmon, A. Lees, F. Finkelman, and D.H. Conrad. 1997. Induction of B cell apoptosis by co-cross-linking CD23 and sIg involves aberrant regulation of c-myc and is inhibited by bcl-2. Int. Immunol. 9:1131-1140.
38. Ikuta, K., M. Takami, C.W. Kim, T. Honjo, T. Miyoshi, Y. Tagaya, T. Kawabe, and J. Yodoi. 1987. Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins. Proc. Natl. Acad. Sci. USA. 84:819-823.
39. Taylor, M.A., K.A. Pratt, D.F. Revell, K.C. Baker, I.G. Sumner, and P.W. Goodenough. 1992. Active papain renatured and processed from insoluble recombinant propapain expressed in Escherichia coli. Protein Eng. 5:455-459.
40. Henry, A.J., J.M. McDonnell, R. Ghirlando, B.J. Sutton, and H.J. Gould. 2000. Conformation of the isolated cepsilon3 domain of IgE and its complex with the high-affinity receptor, FcepsilonRI. Biochemistry. 39:7406-7413.
41. Young, R.J., R.J. Owens, G.A. Mackay, C.M. Chan, J. Shi, M. Hide, D.M. Francis, A.J. Henry, B.J. Sutton, and H.J. Gould. 1995. Secretion of recombinant human IgE-Fc by mammalian cells and biological activity of glycosylation site mutants. Protein Eng. 8:193-199.
42. Myszka, D.G. 1999. Improving biosensor analysis. J. Mol. Recognit. 12:279-284.
43. McDonnell, J.M., R. Calvert, R.L. Beavil, A.J. Beavil, A.J. Henry, B.J. Sutton, H.J. Gould, and D. Cowburn. 2001. The structure of the IgE Cepsilon2 domain and its role in stabilizing the complex with its high-affinity receptor FcepsilonRIalpha. Nat. Struct. Biol. 8:437-441.
44. Brunger, A.T., P.D. Adams, G.M. Clore, W.L. DeLano, P. Gros, R.W. Grosse-Kunstleve, J.S. Jiang, J. Kuszewski, M. Nilges, N.S. Pannu, et al. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54:905-921.
45. McDonnell, J.M., D. Fushman, C.L. Milliman, S.J. Korsmeyer, and D. Cowburn. 1999. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists. Cell. 96:625-634.
46. Lipari, G., and A. Szabo. 1982. Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity. J. Am. Chem. Soc. 104:4546-4559.
47. Walker, O., R. Varadan, and D. Fushman. 2004. Efficient and accurate determination of the overall rotational diffusion tensor of a molecule from (15)N relaxation data using computer program ROTDIF. J. Magn. Reson. 168:336-345.
48. Mori, S., C. Abeygunawardana, P.C. van Zijl, and J.M. Berg. 1996. Water exchange filter with improved sensitivity (WEX II) to study solvent-exchangeable protons. Application to the consensus zinc finger peptide CP-1. J. Magn. Reson. B. 110:96-101.